June 03, 2013
Takeda Pharmaceuticals Co. Ltd. and Eli Lilly & Co. urged a Louisiana federal judge on Friday to dismiss a class action alleging they ripped off taxpayers by hiding the risks of their diabetes drug Actos, saying the plaintiff hadn't properly pled violations of an Arkansas constitutional prohibition on misuse of public funds.